StockWatch
·
Industrial Specialties
Business UpdateMay 27, 2026, 08:47 AM

Milestone Scientific CompuFlo System Reduces Complications by 91%

AI Summary

Milestone Scientific Inc. highlighted the growing clinical adoption of its CompuFlo® Epidural System following new peer-reviewed research from the University of Texas Medical Branch. The study, published in Operative Neurosurgery, demonstrated that CompuFlo-guided epidural access during spinal cord stimulator implantation procedures was associated with a 91% reduction in composite complications compared to conventional techniques. This publication further expands the clinical acceptance of CompuFlo technology across a broad range of procedures, with the system now evaluated or utilized in over 40 universities and medical centers globally.

Key Highlights

  • New peer-reviewed research published in Operative Neurosurgery.
  • CompuFlo-guided epidural access reduced composite complications by 91%.
  • Study focused on spinal cord stimulator (SCS) implantation procedures.
  • CompuFlo technology provides real-time pressure sensing and audible feedback.
  • System evaluated or utilized across over 40 universities and medical centers.
  • Expanding clinical acceptance for ESIs, SCS, obstetric epidurals, and more.